Australia Revenue Cycle Management Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The Revenue Cycle Management market is expanding due to huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., McKesson Corporation, GE Healthcare, Quest Diagnostics, NextGen Healthcare, Inc., eClinicalWorks, and R1 RCM Inc.
Australia Revenue Cycle Management Software Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Revenue Cycle Management Software is expanding as a result of huge growth opportunities created by expanding SMEs across the regions and increasing demand for workflow optimization in both developed and developing nations. This demand is fueling the development of better software systems and procedures for Revenue Cycle Management. Some of the key players in the global Revenue Cycle Management Software Market include Cerner Corporation, Epic Systems Corporation, McKesson Corporation, Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., eClinicalWorks LLC, GE Healthcare, NextGen Healthcare, Inc., Quest Diagnostics Incorporated, and Siemens Healthineers AG.
Australia Sepsis Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sepsis diagnostics is expanding as a result of the growing burden of infectious diseases and government initiatives and funding in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for early diagnosis of sepsis. Some of the key players in the global Sepsis Diagnostics Market include bioM?rieux SA; Becton, Dickinson & Company; Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche AG; Danaher Corp. (Beckman Coulter, Inc.); Luminex Corp.; Bruker Corp.; Cepheid, Bruker Corporation, Immunexpress, Inc., and Koninklijke Philips N.V.
Australia Skilled Nursing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Skilled Nursing is expanding as a result of increasing geriatric population and increasing prevalence of chronic disease. Increasing demand for post-acute are is also fueling the need for specialized and skilled nursing in developing and developed countries. Some of the key players in the global Skilled Nursing Market include Genesis Healthcare Inc., Brookdale Senior Living Inc., Ensign Group Inc., Life Care Centers of America, Kindred Healthcare Inc., Extendicare Inc., Sunrise Senior Living, Atria Senior Living, SavaSeniorCare Administrative Services LLC., and Consulate Health Care.
Australia Soft Tissue Repair Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Repair is expanding as a result of increasing sports-related injuries and a rising aging population. Increasing demand for non-invasive treatment and advancements in technology are fueling the soft tissue repair market. Some of the key players in the global soft tissue repair market are Smith & Nephew, Arthrex, Stryker Corporation, Baxter, Johnson & Johnson, Medtronic, LifeNet Health, Becton, Dickinson and Company, Integra Life Sciences Corporation, CryoLife, Boston Scientific Corporation, Zimmer Biomet, Baxter International, ACell, Tissue Regenix Group, and Aroa Biosurgery.
Australia Spinal Implants Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Spinal Implants is expanding as a result of the rising prevalence of Spinal disorders, injuries, and fractures and the rising demand for advanced medical technology. Spinal cord injuries (SCI) are most common during road accidents and all of these spinal disorders are fueling the development of better procedures and devices for the implantation procedure of the spine. Some of the key players in the global Spinal Implants Market include Medtronic, Zimmer Biomet, Alphatec Spine Inc., RTI Surgical, Stryker, Orthofix US LLC, NuVasive Inc., Globus Medical, Aesculap Inc., Apollo Hospitals Enterprise Ltd., Centinel Spine LLC, Premia Spine, Exactech Inc., Aesculap Inc., Lumitex LLC, Life Spine Inc., and Integra LifeSciences
Australia Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
Australia Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
Australia Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
Australia Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
Australia Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
Australia Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
Australia DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
Australia's cardiovascular disease therapeutics market is expected to witness growth from $1.95 Bn in 2022 to $3.81 Bn in 2030 with a CAGR of 8.72% for the year 2022-2030. The rising prevalence of cardiovascular diseases and the demand for innovative therapeutic options for treatment in Australia is responsible for the expansion of the market. The Australian cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Folarix Pharmaceutical, Adelco Pharmaceuticals, and AstraZeneca are the major players in the Australian cardiovascular disease therapeutics market.
Australia's Dialysis Market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. The incidence of CKD in Australia is on the rise due to factors such as diabetes and hypertension, which are becoming more prevalent in the country. This is driving the demand for dialysis treatment. Fresenius Medical Care is one of the leading players in the market, with a wide range of dialysis products and services, including hemodialysis machines, dialysis concentrates, and dialysis services.
Australia's acne therapeutics market is expected to grow from $120 Mn in 2022 to $226 Mn in 2030 with a CAGR of 8.2% for the forecasted year 2022-2030. More than 90% of Australian teenagers suffer from acne vulgaris which leads to the increasing demand for acne treatment options in Australia thereby driving the growth of Australia's acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Some of the major players in the Australian acne therapeutics market are Sypharma, BioDiem, and Novan.
Australia's anti-ageing therapeutics market is projected to grow from $7 Mn in 2022 to $27 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The increasing elderly population and innovative technological advancements in Australia are responsible for the growth of the market. The Australian anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Clinuvel Pharmaceuticals, EZZ Life Science, and PharmatrophiX are the major competitors in the market.
This report presents a strategic analysis of Australia In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Australia In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
Australia's Teleradiology market size was valued at $28 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030 and will reach $ 77 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Australian teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Vision Radiology, Imaging Central, Global Diagnostics, I-MED Radiology Network and others.
Australia's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.08 Bn in 2022 to $1.78 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022-30. The market will be driven by the increasing demand for efficient and effective healthcare delivery and the availability of healthcare data. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, HealthMatch & Clevertar.
Australia's healthcare insurance market is projected to grow from $24.31 Bn in 2022 to $48.81 Bn by 2030, registering a CAGR of 9.1% during the forecast period of 2022-2030. The main factors driving the growth would be government policies, increasing awareness, rising healthcare costs and the growing geriatric population. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Pheonix Health fund, NIB, HBF, St. Lukes's and Latrobe.
Australia artificial intelligence (AI) in medical Imaging market size was valued at $18 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $222 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to rowing demand for advanced healthcare solutions, the demand for AI in medical imaging is rising across the Australia market. Some of the key players in this market are Harrison.ai (AUS), MaxQ AI (AUS), LBT Innovations (AUS), 4Dx Limited (AUS), Oneview Healthcare (AUS), Siemens Healthineers, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems Australia, and others.
The physiotherapy market in Australia is a growing industry currently valued at $638 Mn in 2022, and the market is estimated to grow to $1,126 Mn at a CAGR of 7.35% for the forecasted period 2022-30. With the increasing demand for physiotherapy services due to an ageing population of over 4.5 Mn and an increase in chronic conditions such as obesity and diabetes. The skyward growth trend is sustained by major players like CPL, Spinal Life Australia, and APE Medical Physiotherapy Equipment.
Australia biosimilars market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.7% from 2022 to 2030 and will reach $1263 Mn in 2030. The market is segmented by product type and indication type. The Australian Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.
Australia's 3D imaging market is projected to grow from $ 0.36 Bn in 2022 to $ 1.37 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by the rising chronic illness incidence and the increasing demand for less invasive treatments. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare, Siemens Healthineers & Australian imaging.